BIOSOLVIX

Serial Number 79387769
Registration 7764367
700

Registration Progress

Application Filed
Nov 30, 2023
Under Examination
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered
Apr 22, 2025

Trademark Image

BIOSOLVIX

Basic Information

Serial Number
79387769
Registration Number
7764367
Filing Date
November 30, 2023
Registration Date
April 22, 2025
Published for Opposition
March 4, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 22, 2025
Registration
Registered
Classes
042 044

Rights Holder

Biosolvix.,Co., Ltd

03
Address
Room No. 16, 11F, 204, Gasan digital 1-ro,
Geumcheon-gu Seoul
KR

Ownership History

Biosolvix.,Co., Ltd

Original Applicant
03
KR

Biosolvix.,Co., Ltd

Owner at Publication
03
KR

Biosolvix.,Co., Ltd

Original Registrant
03
KR

Legal Representation

Attorney
Andrea P. Nguyen

USPTO Deadlines

Next Deadline
2090 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-22)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Jul 22, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 11, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jun 24, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jun 24, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Apr 22, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 22, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 11, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 11, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 11, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 11, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 11, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 11, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 22, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 22, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 22, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 17, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 29, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jul 29, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 2, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 1, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 27, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 30, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 25, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medical research laboratory services; medical research laboratory services; scientific research services for medical purposes; medicine research; scientific analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and research of medical products; consultancy in the field of testing, inspection, research of medical products; pharmaceutical product evaluation; medical and pharmacological research services; consulting services in the fields of medical research laboratory testing; scientific research in the fields of medicine and health and pharmacology; industrial research in the fields of medicine and health and pharmacology; research in the fields of medicine and surgery and specimen analysis; medical research
Class 044
Medical and health assessment services relating to DNA, genetics and genetic testing; telemedicine services; medical and health care clinic services; medical and health care services; conducting of medical examinations; medical examination services; medical care; medical clinic services; medical information; providing information in the field of medicine; medical screening; provision of information relating to medicine

Additional Information

Design Mark
The mark consists of "BIOSOLVIX" below the Korean characters that transliterate to "BIOSOLVIX".
Other
The non-Latin characters in the mark transliterate to "BIOSOLVIX" and this has no meaning in a foreign language.

Classification

International Classes
042 044